Search Results - "GERGERT, V. YA"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Differential diagnosis of idiopathic pulmonary fibrosis by Shmelev, E. I., Ergeshov, A. E., Gergert, V. Ya

    Published in Terapevtic̆eskii arhiv (27-03-2020)
    “…The review is devoted to the urgent problem of modern pulmonology: the differential diagnosis of idiopathic pulmonary fibrosis (ILF). ILF occupies a special…”
    Get full text
    Journal Article
  2. 2

    PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION by Yeremeev, V. V., Shepelkova, G. S., Dukhovlinov, I. V., Gergert, V. Ya

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (13-07-2019)
    “…Since 1924, BCG vaccine is used to protect children from the most severe forms of tuberculosis. At the same time, the protective effect of BCG in adults is…”
    Get full text
    Journal Article
  3. 3

    Changes in Microbiota and Development of Nonspecific Inflammation of Genitals in Female C57Bl/6 Mice after Aerosol Infection with Mycobacterium tuberculosis by Kayukova, S. I., Donnikov, A. E., Bocharova, I. V., Tumanova, E. L., Gergert, V. Ya, Ergeshov, A. E., Nikonenko, B. V.

    “…Infectious process even at the initial stage after aerosol infection with Mycobacterium tuberculosis induced rapid changes in vaginal microbiota in mice. Rapid…”
    Get full text
    Journal Article
  4. 4

    DIAGNOSIS OF BACTEC SAMPLES BY IMMUNOGLOBULINS OF MOUSE HYPERIMMUNE SERA OBTAINED AGAINST MODIFIED ANTIGENS OF THE CELL WALL OF MYCOBACTERIUM TUBERCULOSIS by KOZLOVА, I. V., АVDIENKO, V. G., BАBАYAN, S. S., ANDRIEVSKAYA, I. YU, GERGERT, V. YA

    Published in Tuberkulëz i bolezni lëgkikh (2019)
    “…The objective: using double-site enzyme immunoassay (ELISA) to evaluate the specificity of the antigens of digestive and chemically modified cell walls (CW)…”
    Get full text
    Journal Article
  5. 5

    DURATION OF IMMUNE RESPONSE INDUCED BY THE VACCINE BASED ON RECOMBINANT Ag85, TB10 AND FliC PROTEINS by Yeremeev, V. V., Dukhovlinov, I. V., Orlov, A. I., Shepelkova, G. S., Fedorova, E. A., Balazovsky, M. B., Gergert, V. Ya

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (16-03-2018)
    “…Already about one hundred years BCG remains the only widely used tuberculosis (TB) vaccine. It is known that intensity of the BCG-induced Th1 immune response…”
    Get full text
    Journal Article
  6. 6

    STUDIES ON PROTECTIVE EFFECTS OF A VACCINE, BASED ON RECOMBINANT Ag85, TB10 AND FliC PROTEINS by Yeremeev, V. V., Duhovlinov, I. V., Orlov, A. I., Malenko, A. F., Fedorova, E. A., Balazovsky, M. B., Gergert, V. Ya

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-05-2017)
    “…At present time, there is an obvious need for a new generation of vaccines as the most effective preventive approach, in order to stop spreading of…”
    Get full text
    Journal Article
  7. 7

    DURATION OF IMMUNE RESPONSE INDUCED BY THE VACCINE BASED ON RECOMBINANT Ag85, TB10 AND FliC PROTEINS by Yeremeev, V V, Dukhovlinov, I V, Orlov, A I, Shepelkova, G S, Fedorova, E A, Balazovsky, M B, V Ya Gergert

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-01-2018)
    “…Already about one hundred years BCG remains the only widely used tuberculosis (TB) vaccine. It is known that intensity of the BCG-induced Th1 immune response…”
    Get full text
    Journal Article
  8. 8

    STUDIES ON PROTECTIVE EFFECTS OF A VACCINE, BASED ON RECOMBINANT Ag85, TB10 AND FliC PROTEINS by Yeremeev, V V, Duhovlinov, I V, Orlov, A I, Malenko, A F, Fedorova, E A, Balazovsky, M B, V Ya Gergert

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-01-2017)
    “…At present time, there is an obvious need for a new generation of vaccines as the most effective preventive approach, in order to stop spreading of…”
    Get full text
    Journal Article
  9. 9

    PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION by Vladimir Yeremeev, G S Shepelkova, I V Duhovlinov, V Ya Gergert

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-03-2019)
    “…Since 1924, BCG vaccine is used to protect children from the most severe forms of tuberculosis. At the same time, the protective effect of BCG in adults is…”
    Get full text
    Journal Article
  10. 10

    Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients by A. V. Onyan, V. G. Аvdienko, S. S. Babayan, T. R. Bagdasaryan, V. Ya. Gergert

    Published in Tuberkulëz i bolezni lëgkikh (01-02-2016)
    “…Protease-resistant protein and lipid mycobacterial antigens are present in biological fluids of pulmonary tuberculosis patients. Anti-tuberculosis monoclonal…”
    Get full text
    Journal Article
  11. 11

    Prevention of tuberculosis: current approaches to development of vaccines by Stukova, M A, Zabolotnykh, N V, Vinogradova, T I, Gergert, V Ia, Apt, A S, Kaprel'iants, A S, Erokhin, V V, Iablonskiĭ, P K, Kiselev, O I

    “…This review is focused on recent advances in development of new vaccines for the prevention of tuberculosis. The main reasons for lack of BCG vaccine efficacy…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14